Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Type VII collagen absence helps skin development by allowing tissue remodeling.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Finasteride effectively reduces hair loss by decreasing androgen levels.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Corn silk extract helps reduce prostate enlargement symptoms.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

PCOS women with COVID-19 have higher cardiometabolic risks.